Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03946631 · ClinicalTrials.gov registry record
GDM Post Partum Screening
A clinical trial, sponsored by Pediatrix.
- Terminated
- Registry status
- 21
- Enrollment target
NCT03946631 is a clinical trial that was terminated before completion, run by Pediatrix. The registered enrollment target is 21 participants.
The verdict
NCT03946631 was terminated before completion, sponsored by Pediatrix.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Immediate postpartum screening for diabetes mellitus in women with gestational diabetes The objective of this study is to determine if screening for type 2 diabetes can be done 24 hours after delivery, versus 6-12 weeks postpartum, in recently delivered women having been diagnosed with gestational diabetes requiring medication therapy in the antecedent pregnancy.
Interventions
- DIAGNOSTIC_TEST 2 hour glucose tolerance test using 75g glucose drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-08-20 |
| Est. Completion | 2022-10-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03946631
The ClinicalTrials.gov registry entry for NCT03946631 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2 hour glucose tolerance test using 75g glucose drink is the first listed.
NCT03946631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03946631 about?
NCT03946631 is a clinical study titled "GDM Post Partum Screening". Immediate postpartum screening for diabetes mellitus in women with gestational diabetes The objective of this study is to determine if screening for type 2 diabetes can be done 24 hours after delivery, versus 6-12 weeks postpartum, in recently delivered women having been diagnosed with gestational ...
What is the current status of trial NCT03946631?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2019-08-20. Estimated completion is 2022-10-21.
What interventions are being tested in trial NCT03946631?
The interventions under investigation include: 2 hour glucose tolerance test using 75g glucose drink (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03946631?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.